Thalidomide therapy and deep venous thrombosis in multiple myeloma

被引：55
作者：
Rajkumar, SV [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Coll Med, Div Hematol, Rochester, MN 55905 USA
来源：
MAYO CLINIC PROCEEDINGS | 2005年 / 80卷 / 12期
关键词：
D O I：
10.4065/80.12.1549
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1549 / 1551
页数：3
相关论文
共 42 条
  • [1] Multiple myeloma: How far have we come?
    Anderson, KC
    [J]. MAYO CLINIC PROCEEDINGS, 2003, 78 (01) : 15 - 17
  • [2] [Anonymous], 1994, BMJ
  • [3] Total therapy with tandem transplants for newly diagnosed multiple myeloma
    Barlogie, B
    Jagannath, S
    Desikan, KR
    Mattox, S
    Vesole, D
    Siegel, D
    Tricot, G
    Munshi, N
    Fassas, A
    Singhal, S
    Mehta, J
    Anaissie, E
    Dhodapkar, D
    Naucke, S
    Cromer, J
    Sawyer, J
    Epstein, J
    Spoon, D
    Ayers, D
    Cheson, B
    Crowley, J
    [J]. BLOOD, 1999, 93 (01) : 55 - 65
  • [4] Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients
    Barlogie, B
    Desikan, R
    Eddlemon, P
    Spencer, T
    Zeldis, J
    Munshi, N
    Badros, A
    Zangari, M
    Anaissie, E
    Epstein, J
    Shaughnessy, J
    Ayers, D
    Spoon, D
    Tricot, G
    [J]. BLOOD, 2001, 98 (02) : 492 - 494
  • [5] The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma
    Baz, R
    Li, L
    Kottke-Marchant, K
    Srkalovic, G
    McGowan, B
    Yiannaki, E
    Karam, MA
    Faiman, B
    Jawde, RA
    Andresen, S
    Zeldis, J
    Hussein, MA
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (12) : 1568 - 1574
  • [6] Cavo M, 2004, HAEMATOLOGICA, V89, P826
  • [7] DIMOPOULOS M, 2005, HAEMATOLOGICA S2, V90, P160
  • [8] Treatment of plasma cell dyserasias with thalidomide and its derivatives
    Dimopoulos, MA
    Anagnostopoulos, A
    Weber, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4444 - 4454
  • [9] Adverse effects of thalidomide administration in patients with neoplastic diseases
    Dimopoulos, MA
    Eleutherakis-Papaiakovou, V
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 (07) : 508 - 515
  • [10] Phase II trial of thalidomide in renal-cell carcinoma
    Escudier, B
    Lassau, N
    Couanet, D
    Angevin, E
    Mesrati, F
    Leborgne, S
    Garofano, A
    Leboulaire, C
    Dupouy, N
    Laplanche, A
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (07) : 1029 - 1035
12345